Enlil Adds Eight MedTech Clients in Record Q1 2026

May 15, 2026
Enlil reported a record first quarter of 2026, securing eight new MedTech customers who adopted its AI-powered traceability platform after moving away from legacy quality and product lifecycle systems.

Enlil announced in a press release that it signed eight new MedTech customers in the first quarter of 2026. The companies span several segments including organ perfusion, surgical robotics, imaging, and Software as a Medical Device.

The new clients include Vascular Perfusion Solutions, Verionyx, and iSono Health. Each migrated from legacy quality and product lifecycle management systems such as Greenlight Guru and PTC Arena. Enlil stated that these customers were able to go live on its platform within weeks.

The company noted that its migration team worked with each client to consolidate data from multiple sources and establish new processes without interrupting ongoing development. Enlil described its offering as an integrated AI ready traceability platform designed for medical device and life sciences organizations.

According to the announcement, customers cited flexibility, integration, and private AI capabilities as key reasons for standardizing on Enlil's platform.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/15
Enlil Adds Eight MedTech Customers in Record First Quarter of 2026
05/15
Psynk AI Partners with Ocean View Psychiatric Hospital to Deploy AI Psychiatric Assistant
05/15
AI Screening for Childhood Blindness Begins in Mongolia
05/15
ELLKAY Names Lucky Singh Chief Technology Officer
05/15
Optura Raises $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like